Utilization of neoadjuvant chemotherapy in high‐risk, node‐negative early breast cancer-Reference-Cited by-同舟云学术

Utilization of neoadjuvant chemotherapy in high‐risk, node‐negative early breast cancer

Published:2022-01-05 Issue:4 Volume:11 Page:1099-1108
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Prakash Ipshita¹^ORCID,Neely N. Ben²,Thomas Samantha M.²³,Sammons Sarah³⁴,Blitzblau Rachel C.³⁵,DiLalla Gayle A.⁶,Hyslop Terry²³,Menendez Carolyn S.³⁶,Plichta Jennifer K.³⁶⁷,Rosenberger Laura H.³⁶,Fayanju Oluwadamilola M.⁸⁹¹⁰,Hwang E. Shelley³⁶,Greenup Rachel A.¹⁰¹¹

Affiliation:

1. Department of Surgery Jewish General Hospital McGill University Montreal Quebec Canada

2. Duke Department of Biostatistics & Bioinformatics Durham North Carolina USA

3. Duke Cancer Institute Durham North Carolina USA

4. Department of Medicine Duke University School of Medicine Durham North Carolina USA

5. Department of Radiation Oncology Duke University School of Medicine Durham North Carolina USA

6. Department of Surgery Duke University School of Medicine Durham North Carolina USA

7. Department of Population Health Sciences Duke University School of Medicine Durham North Carolina USA

8. Division of Endocrine and Oncologic Surgery Department of Surgery Perelman School of Medicine The University of Pennsylvania Philadelphia Pennsylvania USA

9. Rena Rowan Breast Center Abramson Cancer Center Philadelphia Pennsylvania USA

10. Yale Department of Surgery Yale School of Medicine New Haven Connecticut USA

11. Yale Cancer Outcomes, Public Policy and Effectiveness Research Center (COPPER) Yale School of Medicine and Yale Cancer Center New Haven Connecticut USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4517

Reference34 articles.

1. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

2. Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902

3. Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27